Wed, November 9, 2022

Swayampakula Ramakanth Maintained (ALXO) at Strong Buy with Decreased Target to $65 on, Nov 9th, 2022

Swayampakula Ramakanth of HC Wainwright & Co., Maintained "ALX Oncology Holdings Inc." (ALXO) at Strong Buy with Decreased Target from $80 to $65 on, Nov 9th, 2022.

Swayampakula has made no other calls on ALXO in the last 4 months.



There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, 0 agree with Swayampakula's Rating of Hold.



This is the rating of the analyst that currently disagrees with Swayampakula


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $38 on, Tuesday, August 9th, 2022